Combination therapies and patient stratification with bispecific anti-EGFR/c-Met antibodies | Patent Number 11459391

US 11459391 B2
Application Number16798662
Publication NumberUS 20200270351 A1
Pendency2 years, 7 months, 13 days
Filled DateFeb 24, 2020
Priority DateFeb 26, 2019
Publication DateAug 27, 2020
Expiration DateFeb 25, 2039
Inventor/ApplicantsSheri Moores
Smruthi Vijayaraghavan
ExaminesLI, RUIXIANG
Art Unit1646
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.